The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Enhanced detection and characterization of targetable EGFR and ERBB2 exon20 insertion mutations in urothelial carcinoma.
 
Andrew Gdowski
Patents, Royalties, Other Intellectual Property - US20220008350A1
 
Kathryn Hacker Gessner
No Relationships to Disclose
 
Emily Kounlavong
No Relationships to Disclose
 
Lucia Kim
No Relationships to Disclose
 
Ryan Matthew Kemper
No Relationships to Disclose
 
Mi Zhou
No Relationships to Disclose
 
Jeffrey Damrauer
No Relationships to Disclose
 
Justin Ashby
No Relationships to Disclose
 
Daniel James Crona
No Relationships to Disclose
 
Kwok-Kin Wong
Stock and Other Ownership Interests - Array BioPharma; Bluebird Bio; G1 Therapeutics
Honoraria - AstraZeneca; Bristol-Myers Squibb; Genocea Biosciences; Janssen Oncology; Merck; Mirati Therapeutics; Novartis; Pfizer
Research Funding - Blueprint Medicines (Inst); BridgeBio Pharma (Inst); Bristol Myers Squibb Foundation (Inst); Delfi Diagnostics (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Takeda (Inst); Tango Therapeutics (Inst)
Travel, Accommodations, Expenses - Takeda
 
William Y. Kim
No Relationships to Disclose